These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 29477074)

  • 1. Benzomorphan scaffold for opioid analgesics and pharmacological tools development: A comprehensive review.
    Turnaturi R; Marrazzo A; Parenti C; Pasquinucci L
    Eur J Med Chem; 2018 Mar; 148():410-422. PubMed ID: 29477074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzomorphan skeleton, a versatile scaffold for different targets: A comprehensive review.
    Turnaturi R; Montenegro L; Marrazzo A; Parenti R; Pasquinucci L; Parenti C
    Eur J Med Chem; 2018 Jul; 155():492-502. PubMed ID: 29908442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of N-substitution in 6,7-benzomorphan compounds.
    Pasquinucci L; Prezzavento O; Marrazzo A; Amata E; Ronsisvalle S; Georgoussi Z; Fourla DD; Scoto GM; Parenti C; Aricò G; Ronsisvalle G
    Bioorg Med Chem; 2010 Jul; 18(14):4975-82. PubMed ID: 20599386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of N-substituent structural variations in opioid receptor profile of LP1.
    Pasquinucci L; Turnaturi R; Aricò G; Parenti C; Pallaki P; Georgoussi Z; Ronsisvalle S
    Bioorg Med Chem; 2016 Jun; 24(12):2832-42. PubMed ID: 27234885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (2S)-N-2-methoxy-2-phenylethyl-6,7-benzomorphan compound (2S-LP2): Discovery of a biased mu/delta opioid receptor agonist.
    Pasquinucci L; Turnaturi R; Calò G; Pappalardo F; Ferrari F; Russo G; Arena E; Montenegro L; Chiechio S; Prezzavento O; Parenti C
    Eur J Med Chem; 2019 Apr; 168():189-198. PubMed ID: 30822708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of novel LP1-based analogues with enhanced delta opioid receptor profile.
    Pasquinucci L; Turnaturi R; Prezzavento O; Arena E; Aricò G; Georgoussi Z; Parenti R; Cantarella G; Parenti C
    Bioorg Med Chem; 2017 Sep; 25(17):4745-4752. PubMed ID: 28734666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New benzomorphan derivatives of MPCB as MOP and KOP receptor ligands.
    Pasquinucci L; Iadanza M; Marrazzo A; Prezzavento O; Ronsisvalle S; Scoto GM; Parenti C; De Luca L; Ronsisvalle G
    Pharmazie; 2007 Nov; 62(11):813-24. PubMed ID: 18065096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, in vitro evaluation, and molecular modeling studies of N-substituted benzomorphans, analogs of LP2, as novel MOR ligands.
    Costanzo G; Patamia V; Turnaturi R; Parenti C; Zagni C; Lombino J; Amata E; Marrazzo A; Pasquinucci L; Rescifina A
    Chem Biol Drug Des; 2023 Jun; 101(6):1382-1392. PubMed ID: 36813756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and pharmacology of 8-amino-3-[(tetrahydro-2-furanyl)methyl] benzomorphan.
    Zhou Q; Duan WH; Cohen DJ; Bidlack JM; Wentland MP
    Yao Xue Xue Bao; 2003 Oct; 38(10):748-53. PubMed ID: 14730897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and Structure-Activity Relationships of LP1 Derivatives: N-Methyl-N-phenylethylamino Analogues as Novel MOR Agonists.
    Turnaturi R; Parenti C; Prezzavento O; Marrazzo A; Pallaki P; Georgoussi Z; Amata E; Pasquinucci L
    Molecules; 2018 Mar; 23(3):. PubMed ID: 29547588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LP1 and LP2: Dual-Target MOPr/DOPr Ligands as Drug Candidates for Persistent Pain Relief.
    Pasquinucci L; Parenti C; Georgoussi Z; Reina L; Tomarchio E; Turnaturi R
    Molecules; 2021 Jul; 26(14):. PubMed ID: 34299443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological studies with a nonpeptidic, delta-opioid (-)-(1R,5R,9R)-5,9-dimethyl-2'-hydroxy-2-(6-hydroxyhexyl)-6,7-benzomorphan hydrochloride ((-)-NIH 11082).
    Aceto MD; May EL; Harris LS; Bowman ER; Cook CD
    Eur J Pharmacol; 2007 Jul; 566(1-3):88-93. PubMed ID: 17434480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophilic gamma-lactone kappa-opioid receptor probes. Analogues of 2'-hydroxy-2-tetrahydrofurfuryl-5,9-dimethyl-6,7-benzomorphan diastereomers.
    Klein P; Nelson WL
    J Med Chem; 1991 Aug; 34(8):2438-44. PubMed ID: 1652019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and structure-activity relationships of 6,7-benzomorphan derivatives as antagonists of the NMDA receptor-channel complex.
    Grauert M; Bechtel WD; Ensinger HA; Merz H; Carter AJ
    J Med Chem; 1997 Aug; 40(18):2922-30. PubMed ID: 9288174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An LP1 analogue, selective MOR agonist with a peculiar pharmacological profile, used to scrutiny the ligand binding domain.
    Ronsisvalle S; Aricò G; Panarello F; Spadaro A; Pasquinucci L; Pappalardo MS; Parenti C; Ronsisvalle N
    Bioorg Med Chem; 2016 Nov; 24(21):5280-5290. PubMed ID: 27624520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of esters and carboxylic acids as the N-substituent of opioids. Part 1: Benzomorphans.
    Metcalf MD; Aceto MD; Harris LS; Woods JH; Traynor JR; Coop A; May EL
    Bioorg Med Chem; 2008 Jan; 16(2):869-73. PubMed ID: 17962026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. X-ray molecular structures and theoretical conformational studies of narcotic analgesics alpha-(-)-N-cis-3-chloroallyl-normetazocine, ethylketazocine, and ketazocine.
    Bandoli G; Grassi A; Pappalardo GC
    J Pharm Sci; 1993 Aug; 82(8):821-8. PubMed ID: 8104247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo binding of benzomorphans to mu, delta and kappa opioid receptors: comparison with urine output in the rat.
    Richards ML; Sadée W
    J Pharmacol Exp Ther; 1985 May; 233(2):425-32. PubMed ID: 2987482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ring-constrained orvinols as analogs of buprenorphine: differences in opioid activity related to configuration of C(20) hydroxyl group.
    Traynor JR; Guo L; Coop A; Lewis JW; Woods JH
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1093-9. PubMed ID: 10565829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Pharmacological Heterogeneity of Nepenthone Analogs in Conferring Highly Selective and Potent κ-Opioid Agonistic Activities.
    Li W; Long JD; Qian YY; Long Y; Xu XJ; Wang YJ; Shen Q; Wang ZN; Yang XC; Xiao L; Sun HP; Xu YL; Chen YY; Xie Q; Wang YH; Shao LM; Liu JG; Qiu ZB; Fu W
    ACS Chem Neurosci; 2017 Apr; 8(4):766-776. PubMed ID: 28033462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.